trending Market Intelligence /marketintelligence/en/news-insights/trending/ytxtmpobcdkhgp2kccey3g2 content esgSubNav
In This List

Profound Medical completes bought-deal offering

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Profound Medical completes bought-deal offering

Mississauga, Ontario-based Profound Medical Corp. completed its upsized bought-deal offering with gross proceeds of C$34.5 million.

The proceeds include the exercise of the underwriters' overallotment option. The company had granted the underwriters the option to buy up to an additional 4.5 million shares.

Profound plans to use the proceeds to advance its clinical trials, expansion of infrastructure to execute on global sales and marketing plans relating to its Tulsa-Pro and Sonavelle systems, to support ongoing research and development and continue to invest in additional research and development and acquisitions to expand the applications of its current and future platform, and for general corporate purposes.

The offering was conducted by a syndicate of underwriters led by Canaccord Genuity Corp. and including Paradigm Capital Inc., CIBC World Markets Inc., Beacon Securities Ltd., Echelon Wealth Partners Inc. and Mackie Research Capital Corp.